Page last updated: 2024-08-25

3-amino-1,2,4-triazine and Adenocarcinoma

3-amino-1,2,4-triazine has been researched along with Adenocarcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Bassani, D; Carbone, D; Cascioferro, S; Cirrincione, G; Dall'Acqua, S; De Franco, M; Diana, P; Gandin, V; Moro, S; Parrino, B; Pavan, M; Pecoraro, C1
Bassani, D; Carbone, D; Cascioferro, S; Cirrincione, G; Dall'Acqua, S; De Franco, M; Diana, P; Gandin, V; Moro, S; Parrino, B; Pavan, M; Pecoraro, C; Sut, S1

Other Studies

2 other study(ies) available for 3-amino-1,2,4-triazine and Adenocarcinoma

ArticleYear
Discovery of the 3-Amino-1,2,4-triazine-Based Library as Selective PDK1 Inhibitors with Therapeutic Potential in Highly Aggressive Pancreatic Ductal Adenocarcinoma.
    International journal of molecular sciences, 2023, Feb-12, Volume: 24, Issue:4

    Topics: Adenocarcinoma; Humans; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Small Molecule Libraries

2023
Structural Manipulations of Marine Natural Products Inspire a New Library of 3-Amino-1,2,4-Triazine PDK Inhibitors Endowed with Antitumor Activity in Pancreatic Ductal Adenocarcinoma.
    Marine drugs, 2023, May-04, Volume: 21, Issue:5

    Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Docking Simulation; Pancreatic Neoplasms; Proto-Oncogene Proteins p21(ras); Triazines

2023